NCT00771459

Brief Summary

The purpose of this study is to examine whether local infiltration analgesia (LIA) with Ropivacaine and adrenaline is effective in the treatment of postoperative pain after major spine surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2008

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

October 10, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 13, 2008

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
Last Updated

June 23, 2011

Status Verified

October 1, 2008

Enrollment Period

10 months

First QC Date

October 10, 2008

Last Update Submit

June 22, 2011

Conditions

Keywords

Local infiltration analgesiapostoperative painropivacaine

Outcome Measures

Primary Outcomes (1)

  • Postoperative Pain

    0-48 h postoperatively

Secondary Outcomes (1)

  • Analgesia consumption

    0-48 h postoperatively

Study Arms (2)

Ropivacaine

ACTIVE COMPARATOR
Drug: Ropivacaine 0.5 %

Placebo

PLACEBO COMPARATOR
Drug: Isotonic NaCl

Interventions

Local infiltration analgesia

Ropivacaine

Local infiltration analgesia

Placebo

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients eligible for major spine surgery
  • must speak and understand Danish
  • must be able to give oral and written consent

You may not qualify if:

  • alcohol or medicine abuse
  • treatment with opioids \> 100 mg daily
  • allergy to local anesthetics
  • severe obesity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hvidovre University Hospital

Copenhagen, Hvidovre, 2650, Denmark

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 10, 2008

First Posted

October 13, 2008

Study Start

October 1, 2008

Primary Completion

August 1, 2009

Study Completion

August 1, 2009

Last Updated

June 23, 2011

Record last verified: 2008-10

Locations